Your browser doesn't support javascript.
loading
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Walker, Brian A; Mavrommatis, Konstantinos; Wardell, Christopher P; Ashby, T Cody; Bauer, Michael; Davies, Faith E; Rosenthal, Adam; Wang, Hongwei; Qu, Pingping; Hoering, Antje; Samur, Mehmet; Towfic, Fadi; Ortiz, Maria; Flynt, Erin; Yu, Zhinuan; Yang, Zhihong; Rozelle, Dan; Obenauer, John; Trotter, Matthew; Auclair, Daniel; Keats, Jonathan; Bolli, Niccolo; Fulciniti, Mariateresa; Szalat, Raphael; Moreau, Philippe; Durie, Brian; Stewart, A Keith; Goldschmidt, Hartmut; Raab, Marc S; Einsele, Hermann; Sonneveld, Pieter; San Miguel, Jesus; Lonial, Sagar; Jackson, Graham H; Anderson, Kenneth C; Avet-Loiseau, Herve; Munshi, Nikhil; Thakurta, Anjan; Morgan, Gareth J.
Afiliação
  • Walker BA; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Mavrommatis K; Celgene Corporation, San Francisco, CA.
  • Wardell CP; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Ashby TC; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Bauer M; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Davies FE; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Rosenthal A; Cancer Research and Biostatistics, Seattle, WA.
  • Wang H; Cancer Research and Biostatistics, Seattle, WA.
  • Qu P; Cancer Research and Biostatistics, Seattle, WA.
  • Hoering A; Cancer Research and Biostatistics, Seattle, WA.
  • Samur M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Towfic F; Celgene Corporation, Summit, NJ.
  • Ortiz M; Celgene Institute of Translational Research Europe, Sevilla, Spain.
  • Flynt E; Celgene Corporation, Summit, NJ.
  • Yu Z; Celgene Corporation, Summit, NJ.
  • Yang Z; Celgene Corporation, Summit, NJ.
  • Rozelle D; Rancho BioSciences, San Diego, CA.
  • Obenauer J; Rancho BioSciences, San Diego, CA.
  • Trotter M; Celgene Institute of Translational Research Europe, Sevilla, Spain.
  • Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT.
  • Keats J; Translational Genomics Research Institute, Phoenix, AZ.
  • Bolli N; Department of Oncology, University of Milan, Milan, Italy.
  • Fulciniti M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Szalat R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Moreau P; Department of Hematology, University of Nantes, Nantes, France.
  • Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA.
  • Stewart AK; Department of Hematology, Mayo Clinic, Scottsdale, AZ.
  • Goldschmidt H; Department of Medicine V, Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Raab MS; Department of Medicine V, Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Einsele H; German Cancer Research Center, Heidelberg, Germany.
  • Sonneveld P; Department of Internal Medicine II, Wurzburg University, Wurzburg, Germany.
  • San Miguel J; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Lonial S; Centro Investigacion Medica Aplicada, Clinica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Oncología, Pamplona, Spain.
  • Jackson GH; Winship Cancer Institute, Emory University, Atlanta, GA.
  • Anderson KC; Department of Haematology, Newcastle University, Newcastle, United Kingdom.
  • Avet-Loiseau H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Munshi N; Centre de Recherche en Cancérologie de Toulouse Institut National de la Santé et de la Recherche Médicale U1037, Toulouse, France; and.
  • Thakurta A; L'Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire, Toulouse, France.
  • Morgan GJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Blood ; 132(6): 587-597, 2018 08 09.
Article em En | MEDLINE | ID: mdl-29884741

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncogenes / Regulação Neoplásica da Expressão Gênica / Mutagênese / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Argentina

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncogenes / Regulação Neoplásica da Expressão Gênica / Mutagênese / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Argentina